Bayer (BAYRY)
(Delayed Data from OTC)
$8.12 USD
+0.16 (2.01%)
Updated Sep 24, 2024 03:59 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 17% (80 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 2.05 | 9.99 |
Current Quarter Estimate | 0.17 | 37.63 | 61.00 |
Year Ago Quarter Estimate | 0.10 | 12.41 | 54.84 |
Next Quarter Estimate | NA | 38.42 | 63.00 |
Next Year Estimate | 1.44 | 173.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -20.23 | 6.60 | 15.67 |
Next Year | 4.35 | 16.80 | 11.34 |
Last 5 Years | -0.90 | 2.90 | 8.10 |
Next 5 Years | NA | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 4.91 | 22.31 |
Price/Book (MRQ) | 0.76 | 5.90 |
Price/Cash Flow (MRFY) | 2.07 | 12.12 |
Dividend Yield | 0.27% | 2.12% |
Net Profit Margin (TTM) | -2.74% | 18.86% |
Return on Equity (TTM) | 16.96% | 34.56% |
Debt to Equity (MRQ) | 1.04 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.